The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Precancerous neoplastic cells can move through the pancreatic ductal system
Open accessAbstract
Most adult carcinomas develop from noninvasive precursor lesions, a progression that is supported by genetic analysis. However, the evolutionary and genetic relationships among co-existing lesions are unclear. Here we analysed the somatic variants of pancreatic cancers and precursor lesions sampled from distinct regions of the same pancreas. After inferring evolutionary relationships, we found that the ancestral cell had initiated and clonally expanded to form one or more lesions, and that subsequent driver gene mutations eventually led to invasive pancreatic cancer. We estimate that this multi-step progression generally spans many years. These new data reframe the step-wise progression model of pancreatic cancer by illustrating that independent, high-grade pancreatic precursor lesions observed in a single pancreas often represent a single neoplasm that has colonized the ductal system, accumulating spatial and genetic divergence over time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent phylogenetic analyses of precursor lesions from the pancreata of patients with established cancer have confirmed the stepwise progression model and accumulation of genetic alterations in the transition from PanINs to PDAC postulated using more rudimentary techniques26.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Self-citationA framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,508
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Self-citationSpencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,965
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationGenomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Self-citation
Cited by
Sorted by citations
Items 101–120 of 120
Schäfer, D. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8485
El aynara en el reflan djudeo-espanyol
Koén-Sarano, M. (2009) · AKI YERUSHALAYIM: Revista Kulturala Djudeo-espanyola
Genomic medicine for the early detection of pancreatic cancer
Sato, H., Takahashi, K., & Mizukami, Y. (2022) · Suizo · doi:10.2958/suizo.37.29
Pancreatic Intraepithelial Neoplasia
Campbell, F., & Verbeke, C. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-49848-1_8
Metachronous bile duct cancers originate from primary cancer clonesPreprint
Aoki, S., Omori, Y., Inoue, K., Iseki, M., Nakayama, S., Douchi, D., Miura, T., Ishida, M., Ohtsuka, H., Mizuma, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1832174/v1
Ductal Adenocarcinoma and Pancreatic Intraepithelial Neoplasia
(2023) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477275-07
Tsutsumi, K., & Otsuka, M. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.177
Molecular genetic bases and pathways of carcinogenesis in the pancreas
Solonitsyn, E., Seyfedinova, S. S., Kalinina, O., & Freylikhman, O. (2023) · Russian Journal for Personalized Medicine · doi:10.18705/27823806-2023-3-3-91-98
“Точно так же в поражениях PanIN моделирование на основе данных секвенирования предполагает интервал примерно в 4 года между общей предковой клеткой и клеткой-основателем, ассоциированной с РПЖ [15].”
Tumori benigni del pancreas esocrino
Munoz, L. A., & Rebours, V. (2024) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(24)48826-8
Tumores benignos del páncreas exocrino
Munoz, L. A., & Rebours, V. (2024) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(24)49312-4
Three Molecular Developmental Pathways of Remnant Pancreatic Cancer After Resection
Suzuki, S., Omori, Y., Ono, Y., Hirose, K., Itoh, T., Karasaki, H., Shimoda, M., Nagakawa, Y., Higuchi, R., Endo, I., et al. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006444
“…through a positive surgical margin, (2) through intraparenchymal metastases, or (3) as metachronous neoplasms independent of the primary PC. 7 14 – 17 Our study examined remnant PCs resected after the resection of primary PCs with negative margins without recurrence within 1 year after the…”
Competition for resources can reshape the evolutionary properties of spatial structure
Devadhasan, A., Kolodny, O., & Carja, O. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012542
Paklina, O. V., Noskova, K. K., Abramov, I. S., Бодунова, Н. А., & Савелов, Н. А. (2025) · Annaly khirurgicheskoy gepatologii = Annals of HPB surgery · doi:10.16931/1995-5464.2025-3-53-62
Bravo, A. C., Cruz, R., Fernandes, A., Bispo, M., Boas, F. V., Gonçalves, T. C., Rodrigues‐Pinto, E., & Fidalgo, C. A. (2025) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000549925
“To explain multifocal disease, it was proposed that, as different lesions frequently arise from the same cell clone, cells can spread (continuously or discontinuously) through the fluid along pancreatic ductal system [56].”
Spadafora, V. K., Pryce, B. R., Oles, A., Talbert, E. E., Romeo, M. J., Vaena, S. G., Berto, S., Ostrowski, M. C., Wang, D. J., & D, D. C. G. (2024) · Figshare · doi:10.6084/m9.figshare.25538517
Ciblage pharmacologique du microenvironnement de l'adénocarcinome canalaire pancréatique
Samain, R. (2018) · theses.fr (ABES) · doi:10.70675/e35639a1z6534z4cb6z9efbza38473efebed
Mačinga, P., Zahradník, J., Hucl, T., & Janoštiak, R. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.120019
Paja-García, A., Romero-Becerra, R., Aittokallio, T. A., & Lopez, A. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014735
IPMN beyond the cyst: toward a broader framework of pancreatic and systemic cancer susceptibility
Okabayashi, T., Tabuchi, M., Tokumaru, T., Uemura, S., & Tamura, S. (2026) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2026.2737415
Masuda, A., Tsujimae, M., Ko, T., Miki, M., Okamoto, K., Ogawa, K., Kageyama, T., Tokunaga, T., Kawase, Y., Kanamaru, K., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11014749/v1
Metadata
- Authors
- Makohon-Moore, A. P., Matsukuma, K., Zhang, M., Reiter, J. G., Gerold, J. M., Jiao, Y., Sikkema, L., Attiyeh, M. A., Yachida, S., Sandone, C., Hruban, R. H., Klimstra, D. S., Papadopoulos, N., Nowak, M. A., Kinzler, K. W., Vogelstein, B., & Iacobuzio-Donahue, C. A.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California, Davis (US)
- Johns Hopkins University (US)
- Harvard University (US)
- The University of Osaka (JP)
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Nature
- Published
- 2018-09
- Volume
- 561
- Issue
- 7722
- Pages
- 201-205
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6342205
- OpenAlex
- W2888908131
- Cited by
- 120
- References
- 47
- Citations by year
- 2026: 13 · 2025: 7 · 2024: 14 · 2023: 17 · 2022: 13 · 2021: 13 · 2020: 20 · 2019: 19 · 2018: 3
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Lustgarten Foundation
- Virginia and D.K. Ludwig Fund for Cancer Research
- Rolfe Pancreatic Cancer Foundation
- Austrian Science Fund (J 3996)
- National Institutes of Health (CA062924)
- National Cancer Institute (T32CA067751, T32CA160001, F31CA180682, P50CA062924, P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic cancer, pancreatic precursor lesions, somatic mutations, clonal evolution, tumor progression, pancreatic ductal system, tumor heterogeneity, driver mutations
- MeSH terms
- Exome Sequencing, Humans, Models, Biological, Neoplasm Invasiveness, Pancreatic Ducts, Pancreatic Neoplasms, Precancerous Conditions, Time Factors, Mutagenesis, Disease Progression, Cell Lineage, Evolution, Molecular, Polymorphism, Single Nucleotide, Carcinoma, Pancreatic Ductal, INDEL Mutation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
